Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 11.32 0.22 (1.98%) Market Cap: 1.50 Bil Enterprise Value: 1.48 Bil PE Ratio: 0 PB Ratio: 3.59 GF Score: 75/100

Q3 2022 Maravai LifeSciences Holdings Inc Earnings Call Transcript

Nov 02, 2022 / 09:00PM GMT
Release Date Price: $15.36 (-6.51%)
Operator

Greetings, and welcome to Maravai LifeSciences Third Quarter 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Debra Hart, Head of Investor Relations. Thank you. You may begin.

Debra Hart
Maravai LifeSciences Holdings, Inc. - Senior Director of IR

Thanks, Doug. Good afternoon, everyone, and thanks for joining us for our third quarter 2022 earnings call. I'm joined by Carl Hull, our Executive Chairman and Interim CEO; and Kevin Herde, our Executive Vice President and Chief Financial Officer. Our press release and the slides that accompany today's call are posted on our website and are available at investors.maravai.com under Financial Information, Quarterly Results.

As you can see on Slide 2, Carl will first provide you with a business update, and then Kevin will review our financial results and guidance. We will open the call for questions following the prepared remarks.

On Slide 3, we remind you that the forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot